New lung implant could help severe emphysema patients breathe easier

NCT ID NCT07086339

Recruiting now Disease control Sponsor: Pulmair Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the IAB 50 Flex, an implantable artificial bronchus for adults with severe COPD or emphysema. The trial will enroll 20 participants across two hospitals to check if the implant is safe and if it helps improve breathing and daily activity. The main goal is to see if there are any serious side effects related to the device or procedure within 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: implantable pulmonary stent (IAB 50 Flex)
What this could lead to: If successful, this implant could offer a new way to help people with severe emphysema breathe easier and improve daily function.
What could go wrong: This is a very early, small trial (20 people) focused on safety, not yet proven to work. The implant may cause serious side effects or not help breathing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset lung disorder pulmonary emphysema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD EMPHYSEMA

Contacts and locations

Locations

DUPUYTREN University Hospital
RECRUITING

Limoges, 87000, France
University Medical Center Groningen
RECRUITING

Groningen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.